|
|
Volumn 107, Issue 6, 2011, Pages 523-528
|
|
Factors that predict the success of cyclosporine treatment for chronic urticaria
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CYCLOSPORIN;
STEROID;
THYROID ANTIBODY;
ABDOMINAL PAIN;
ADULT;
ARTHRALGIA;
ARTICLE;
ATOPY;
AUTOLOGOUS SERUM SKIN TESTING;
BLURRED VISION;
CHRONIC URTICARIA;
CHRONIC URTICARIA INDEXES;
DIARRHEA;
DISEASE DURATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG INDUCED HEADACHE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
EDEMA;
FATIGUE;
FEMALE;
FOLLOW UP;
HUMAN;
HYPERTENSION;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL HISTORY;
MEDICAL RECORD REVIEW;
NEUROPATHY;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROGNOSIS;
REMISSION;
SCORING SYSTEM;
SEDATION;
SEX DIFFERENCE;
SIDE EFFECT;
SKIN TEST;
URINE SEDIMENT;
WOUND HEALING IMPAIRMENT;
ADMINISTRATION, ORAL;
ADULT;
CHRONIC DISEASE;
COHORT STUDIES;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
RETROSPECTIVE STUDIES;
URTICARIA;
|
|
EID: 82955227419
PISSN: 10811206
EISSN: 15344436
Source Type: Journal
DOI: 10.1016/j.anai.2011.08.013 Document Type: Article |
|
Times cited : (40)
|
|
References (9)
|
